相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasmodium vivax in the Era of the Shrinking P. falciparum Map
Ric N. Price et al.
TRENDS IN PARASITOLOGY (2020)
Malaria impact on cognitive function of children in a peri-urban community in the Brazilian Amazon
Raquel Tapajos et al.
MALARIA JOURNAL (2019)
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Robert J. Commons et al.
BMC MEDICINE (2019)
Characterising residual malaria transmission in forested areas with low coverage of core vector control in central Viet Nam
Hannah Margaret Edwards et al.
PARASITES & VECTORS (2019)
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient
Sampa Pal et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam
Nguyen Chinh Phong et al.
MALARIA JOURNAL (2019)
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
A. Llanos-Cuentas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
M. V. G. Lacerda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial
Nilay Thakkar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria
J. Kevin Baird et al.
JAMA NETWORK OPEN (2018)
A Randomized Comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam
Phung Duc Thuan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Global Epidemiology of Plasmodium vivax
Rosalind E. Howes et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
Pamela L. St Jean et al.
MALARIA JOURNAL (2016)
Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei
Erin E. Milner et al.
MALARIA JOURNAL (2016)
Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria
David Tenero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax
Brice Campo et al.
PATHOGENS AND GLOBAL HEALTH (2015)
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study
Alejandro Llanos-Cuentas et al.
LANCET (2014)
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects
Ann K. Miller et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The anaemia of Plasmodium vivax malaria
Nicholas M. Douglas et al.
MALARIA JOURNAL (2012)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
分享论文
